ISOTRETINOIN

Course overview

ISOTRETINOIN IS AN ORAL PRESCRIPTION MEDICATION THAT AFFECTS SEBACEOUS GLANDS AND IS USED TO TREAT SEVERE ACNE. THE DRUG WAS APPROVED BY THE US FOOD AND DRUG ADMINISTRATION (FDA) IN 1982 TO TREAT SEVERE, RESISTANT, NODULAR ACNE THAT IS UNRESPONSIVE TO CONVENTIONAL THERAPY, INCLUDING SYSTEMIC ANTIBIOTICS. NON-FDA-APPROVED INDICATIONS INCLUDE MODERATE ACNE, CUTANEOUS T-CELL LYMPHOMAS, NEUROBLASTOMA, AND PREVENTION OF SQUAMOUS CELL CARCINOMA IN HIGH-RISK PATIENTS. ISOTRETINOIN HAS ALSO BEEN USED IN THE TREATMENT OF ROSACEA, FOLLICULITIS, AND PYODERMA FACIALE. THIS ACTIVITY COVERS ISOTRETINOIN, INCLUDING MECHANISM OF ACTION, PHARMACOLOGY, ADVERSE EVENT PROFILES, ELIGIBLE PATIENT POPULATIONS, CONTRAINDICATIONS, MONITORING, AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN THE MANAGEMENT OF ISOTRETINOIN THERAPY.